Prednisolone Market Size, Share, Growth, and Industry Analysis, By Type (Tablets, and Oral Solution), By Application (Rheumatoid Arthritis, Bell's Palsy, Acute Lymphoblastic Leukemia, Autoimmune Hepatitis, Systemic Lupus Erythematosus, Dermatomyositis, Vasculitis, and Crohn's Disease), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

PREDNISOLONE MARKET OVERVIEW

The global prednisolone market size was USD 0.18 billion in 2024 and the market is projected to touch USD 0.37 billion by 2033 at a CAGR of 8.14% during the forecast period.

The prednisolone, a synthetic corticosteroid, finds extensive use in the pharmaceutical sector. Derived from prednisone, it serves as a crucial medication due to its potent anti-inflammatory and immunosuppressive qualities. Structurally, prednisolone mimics the natural corticosteroids produced by the human adrenal glands.

COVID-19 IMPACT

Increased Demand for Anti-Inflammatory Drugs among Population to Fuel Market Growth

The COVID-19 pandemic has been unprecedented and staggering, with experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden decline in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The prednisolone, classified as an anti-inflammatory medication, saw heightened demand during the COVID-19 pandemic due to the occurrence of severe inflammatory reactions in certain patients. This increased demand stemmed from the need to utilize anti-inflammatory drugs like prednisolone in the management of COVID-19 symptoms and related complications.

The pharmaceutical supply chain on a global scale faced disruptions throughout the pandemic, impacting both the manufacturing and distribution of medications, including prednisolone. Consequently, certain regions experienced shortages in the supply of this medication.

LATEST TRENDS

Growing Demand for Anti-Inflammatory Medications, and Focus on Generic Variants to Fuel Market Growth

Chronic inflammatory disorders, including conditions like rheumatoid arthritis, inflammatory bowel disease, and asthma, have been experiencing a global upswing. These ailments typically demand ongoing management, often requiring the use of anti-inflammatory medications like prednisolone. The prevalence of these conditions has increased due to a combination of factors, including the aging population and shifting lifestyles. Additionally, autoimmune disorders, characterized by the body's immune system attacking its own tissues, are on the rise. Conditions such as lupus, multiple sclerosis, and psoriasis necessitate the use of anti-inflammatory medications for both symptom control and disease management. The popularity of generic prednisolone has been on the rise due to its cost-effective nature, providing an economical alternative to branded medications. This trend has been propelled by initiatives aimed at lowering healthcare expenditures.

Request a Free sample to learn more about this report

PREDNISOLONE MARKET SEGMENTATION

By Type

Based on Type prednisolone market is classified as Tablets, and Oral Solution.

By Application

Based on Application prednisolone market is classified as Rheumatoid Arthritis, Bell's Palsy, Acute Lymphoblastic Leukemia, Autoimmune Hepatitis, Systemic Lupus Erythematosus, Dermatomyositis, Vasculitis, and Crohn's Disease.

DRIVING FACTORS

Aging Population to Fuel Market Growth 

As the global population continues to age, the prevalence of age-related health conditions is on the rise, contributing to prednisolone market growth. Many of these conditions, such as osteoarthritis, chronic obstructive pulmonary disease (COPD), and specific cardiovascular diseases, are characterized by inflammation. Consequently, the increasing demand for prednisolone to manage the inflammatory symptoms associated with these health issues is a key driver of market growth.

Increasing Prevalence of Inflammatory Conditions to Stimulate Market Progress

In recent times, there has been a consistent rise in the prevalence of chronic inflammatory conditions on a global scale. Ailments like rheumatoid arthritis, inflammatory bowel disease (IBD), and asthma are progressively becoming more widespread. These conditions demand extended-term management, frequently necessitating the use of anti-inflammatory medications like prednisolone to effectively manage symptoms and enhance the quality of life for patients.

RESTRAINING FACTORS

Side Effects and Safety Concerns to Harm Market Growth

The prednisolone, similar to other corticosteroids, can lead to various side effects, particularly when used over an extended period. These side effects encompass weight gain, elevated blood pressure, osteoporosis, and heightened vulnerability to infections. Concerns about safety may discourage certain patients and healthcare professionals from considering prednisolone as a viable treatment choice.

• Request a Free sample to learn more about this report

•  

PREDNISOLONE MARKET REGIONAL INSIGHTS

North America Leverages Its Well-Developed Pharmaceutical Sector To Drive Market Share 

North America, with a notable emphasis on the United States, commands a substantial prednisolone market share. The region leverages its well-developed pharmaceutical sector, playing a pivotal role in ensuring the widespread availability and distribution of prednisolone products. The prednisolone market in North America benefits from a considerable market share driven by the elevated prevalence of inflammatory conditions, autoimmune disorders, and allergies. Prescription patterns and the overall market dynamics are profoundly influenced by regulatory standards and healthcare practices that hold a significant share of the market within the region.

KEY INDUSTRY PLAYERS

Multitude Of Companies That Played A Pivotal Role In Expansion Of Prednisolone

Within the prednisolone market, numerous influential industry participants operate, encompassing pharmaceutical firms and manufacturers engaged in the manufacturing, distribution, and promotion of prednisolone products. Among these, Teva stands out as a global pharmaceutical company renowned for its extensive portfolio of generic medications, which includes prednisolone offerings.

List of Top Prednisolone Companies

• Shandong Taihua Bio &Tech (China)
• Mahima life Sciences (India)
• Sanofi (France)
• Wuhan DKY Technology (China)
• Xianju Pharma (China)

REPORT COVERAGE

The future demand for the prednisolone market is covered in this study. The Research report includes the Impact of Increased Demand for Anti-Inflammatory Drugs due to the Covid-19 Impact. The report covers the latest trends in Growing Demand for Anti-Inflammatory Medications. The paper includes a segmentation of the prednisolone market. The research paper includes the driving factors that are Aging Population to Fuel Market Growth. The report also covers information on Regional Insights where the region which has emerged leading market for prednisolone.